NFYB Antibody (N-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P25208 |
---|---|
Clone Names | 100430297 |
Gene ID | 4801 |
---|---|
Other Names | Nuclear transcription factor Y subunit beta, CAAT box DNA-binding protein subunit B, Nuclear transcription factor Y subunit B, NF-YB, NFYB, HAP3 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | NFYB |
---|---|
Synonyms | HAP3 |
Function | Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'-CCAAT-3' box motif found in the promoters of its target genes. NF-Y can function as both an activator and a repressor, depending on its interacting cofactors. |
Cellular Location | Nucleus. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene is one subunit of atrimeric complex, forming a highly conserved transcription factorthat binds with high specificity to CCAAT motifs in the promoterregions in a variety of genes. This gene product, subunit B, formsa tight dimer with the C subunit, a prerequisite for subunit Aassociation. The resulting trimer binds to DNA with highspecificity and affinity. Subunits B and C each contain ahistone-like motif. Observation of the histone nature of thesesubunits is supported by two types of evidence; protein sequencealignments and experiments with mutants.
References
Stros, M., et al. Nucleic Acids Res. 37(7):2070-2086(2009)Kang, J.H., et al. J. Cell. Biochem. 104(4):1192-1203(2008)Raju, C.S., et al. Mol. Biol. Cell 19(7):3008-3019(2008)Di Agostino, S., et al. Cancer Cell 10(3):191-202(2006)Kahle, J., et al. Mol. Cell. Biol. 25(13):5339-5354(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.